Clin2
NCT07098091Possibly a fitEnrolling by invitation

Testing the safety of YD0293 in healthy adults

Healthy Participants

This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
78 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are generally healthy with no major medical conditions (like heart, liver, or kidney problems).
  • You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control during the trial and for 3 months after.
  • You haven't taken any medications or supplements in the 2 weeks before the study starts (except as allowed by the doctor).
  • You don't smoke heavily (5+ cigarettes a day) or drink alcohol heavily (more than 14 drinks a week), and can stop during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality
NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

NCT07290283Recruiting· Phase 1
Testing safety of AZD3974 in healthy volunteers

This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.

Glendale, California
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT06867393Recruiting· Phase 1
Safety study of HL-003 in healthy volunteers

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Suzhou, Jiangsu
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.